9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 101 filers reported holding 9 METERS BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $24,000 | -17.2% | 107,754 | 0.0% | 0.00% | – |
Q2 2022 | $29,000 | -92.2% | 107,754 | -82.6% | 0.00% | – |
Q1 2022 | $371,000 | -38.7% | 617,579 | 0.0% | 0.00% | – |
Q4 2021 | $605,000 | -20.3% | 617,579 | +5.9% | 0.00% | – |
Q3 2021 | $759,000 | +32.9% | 583,134 | +12.4% | 0.00% | – |
Q2 2021 | $571,000 | +613.8% | 518,627 | +662.2% | 0.00% | – |
Q1 2021 | $80,000 | – | 68,039 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 25,716,755 | $20,489,000 | 0.26% |
Atlas Private Wealth Advisors | 20,000 | $16,000 | 0.01% |
Lindbrook Capital, LLC | 40,000 | $33,000 | 0.01% |
Prospera Financial Services Inc | 15,000 | $12,000 | 0.01% |
Virtu Financial LLC | 37,982 | $31,000 | 0.01% |
Cypress Wealth Services, LLC | 25,500 | $21,000 | 0.01% |
ExodusPoint Capital Management, LP | 180,096 | $147,000 | 0.00% |
Qube Research & Technologies Ltd | 232,248 | $189,000 | 0.00% |
Ashfield Capital Partners, LLC | 33,353 | $27,000 | 0.00% |
Heritage Wealth Advisors | 20,000 | $16,300,000 | 0.00% |